Database of patients undergoing liver surgery
Official title: Institut Paoli Calmettes Hepatic Surgery Database
Run by Institut Paoli-Calmettes · NCT03686137 · Data updated 2026-11-12
This study collects information from patients who have liver surgery to help doctors and researchers understand how these surgeries work and how patients respond.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Institut Paoli-Calmettes Academic / other |
| Locations | 1 site (Marseille, Bouches Du Rhone) |
| Status | Recruiting |
| Started | November 6, 2017 |
| Main results expected | November 2030 |
| Study ends | November 2030 |
| Registry record updated | September 26, 2018 |
| Trial ID | NCT03686137 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients scheduled to undergo liver surgery for benign tumors or liver cancer.
✕Probably not a fit
Patients who refuse to participate in the study will not receive any benefit from this data collection.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects data from patients who undergo hepatic surgery for benign diseases, as well as primary or secondary liver cancer at the Institut Paoli-Calmettes. The aim is to create a comprehensive database that can be used for future research and analysis related to liver surgery outcomes. By gathering detailed information on surgical procedures and patient demographics, the study seeks to enhance understanding of liver surgery practices and patient responses. This database will serve as a valuable resource for clinicians and researchers in the field.
Why it matters
Potential benefit: If successful, this database could improve surgical outcomes and patient care in liver surgery by providing insights into best practices and patient management.
How similar studies have gone: While this approach is observational and may not have direct precedents, similar databases have been successful in enhancing understanding and outcomes in other surgical fields.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient undergoing liver surgery for benign liver tumor, primary or secondary liver cancer Exclusion Criteria: * Patient refusal
Where it's running
-
Institut Paoli Calmettes
Marseille, Bouches Du Rhone, France Recruiting
Study contacts
- Principal investigator: Ugo Marchese — Institut Paoli-Calmettes
- Study coordinator: Dominique Genre, MD
- Email: drci.up@ipc.unicancer.fr
- Phone: +33491223778
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting post-surgery treatment for liver cancer using AI and whole-slide images
Aims to see if an AI model based on postoperative tissue images and imaging data can help decide if patients with hepatocellular carcinoma should receive adjuvant therapy after surgery.
-
Preventing lung complications after laparoscopic liver surgery
This will test whether extra breathing exercises and perioperative pulmonary physiotherapy can lower lung complications in adults having elective laparoscopic liver surgery.
-
Sports-inspired Onco-Coaching for Young Adults in Cancer Remission
We’re testing a sports-style coaching program to support young adults 18–25 who are in cancer remission, to see how many start the coaching and attend the first two sessions.
-
Metabolic and Microenvironment Patterns in Metastatic Pancreatic Cancer
Researchers are testing how metabolism and surrounding cells in pancreatic cancer relate to treatment responses, using biopsies and blood samples from patients with metastatic disease.
-
Biomarkers and Targets for Lung Immunotherapy in NSCLC
This study tests blood and tumor biomarkers to see who among adults with non-small cell lung cancer might respond to immunotherapy.
-
Evaluating the role of radiology manipulators in cancer imaging interpretation
This study is testing if a new tool can help doctors read cancer imaging better and faster by checking their work before they make a final report.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.